Df. Gunther et al., Androgen-accelerated bone maturation in mice is not attenuated by Faslodex, an estrogen receptor blocker, BONE, 28(4), 2001, pp. 410-413
Androgens accelerate bone maturation, but it is unclear to what extent this
process may be mediated by estrogens derived from aromatization of androge
ns, In this study, we investigated whether an estrogen-blocking agent, Fasl
odex (ICI 182,780), can attenuate testosterone-accelerated skeletal maturat
ion in immature mice. On days of Life 2-8, mouse pups received either testo
sterone propionate (50 mug/100 g body weight), Faslodex (100 mug/100 g body
weight), a combination of Faslodex + testosterone, or vehicle alone, Skele
tal maturation was assessed in the forepaw and the lumbar spine, Testostero
ne caused acceleration of bone maturation (p < 0.05, compared with vehicle)
, predominantly of axial bones, Faslodex, however, failed to block the effe
ct of testosterone, such that the mice receiving Faslodex + testosterone ha
d skeletal maturation scores similar to those treated with testosterone alo
ne. These results suggest that androgens have the capacity to stimulate bon
e maturation directly, probably via their own receptors, (Bone 28:410-413;
2001) (C) 2001 by Elsevier Science Inc. All rights reserved.